Arte Medicae Celeris: what changed
Arte Medicae Celeris
Largest movements
- Current investments +€55,000
new in 2025: €55,000
- Receivables within one year +€20,153
up €20,153 (+107%), from €18,791 to €38,943
of which Other amounts receivable: +€19,565
- Tangible fixed assets -€12,083
down €12,083 (-24.9%), from €48,563 to €36,480
- Cash -€10,290
down €10,290 (-8.6%), from €120,318 to €110,028
mainly Current investments (-€55,000) and Receivables within one year (-€20,153)
- Reserves +€70,263
up €70,263 (+64.4%), from €109,170 to €179,433
- Debts after one year -€11,582
down €11,582 (-30.0%), from €38,565 to €26,982
- Tax, wage and social debts -€7,017
down €7,017 (-25.3%), from €27,715 to €20,697
of which Taxes: -€7,017
- Gross operating margin -€31,887
down €31,887 (-23.3%), from €136,655 to €104,768
- Taxes -€5,434
down €5,434 (-19.6%), from €27,715 to €22,281
- Financial income +€5,249
up €5,249 (+11,647%), from €45 to €5,294
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €187,672 | €240,452 | +€52,780 | +28.1% |
| Fixed assets | 21/28 | €48,563 | €36,480 | -€12,083 | -24.9% |
| Tangible fixed assets | 22/27 | €48,563 | €36,480 | -€12,083 | -24.9% |
| Leasing and similar rights | 25 | €48,563 | €36,480 | -€12,083 | -24.9% |
| Current assets | 29/58 | €139,109 | €203,971 | +€64,863 | +46.6% |
| Amounts receivable within one year | 40/41 | €18,791 | €38,943 | +€20,153 | +107% |
| Trade receivables | 40 | €3,296 | €3,884 | +€587 | +17.8% |
| Other amounts receivable | 41 | €15,494 | €35,059 | +€19,565 | +126% |
| Current investments | 50/53 | - | €55,000 | +€55,000 | |
| Cash at bank and in hand | 54/58 | €120,318 | €110,028 | -€10,290 | -8.6% |
| Total equity and liabilities | 10/49 | €187,672 | €240,452 | +€52,780 | +28.1% |
| Equity | 10/15 | €110,170 | €180,433 | +€70,263 | +63.8% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €109,170 | €179,433 | +€70,263 | +64.4% |
| Distributable reserves | 133 | €109,170 | €179,433 | +€70,263 | +64.4% |
| Amounts payable | 17/49 | €77,502 | €60,019 | -€17,483 | -22.6% |
| Amounts payable after more than one year | 17 | €38,565 | €26,982 | -€11,582 | -30.0% |
| Financial debts | 170/4 | €38,565 | €26,982 | -€11,582 | -30.0% |
| Amounts payable within one year | 42/48 | €38,938 | €32,317 | -€6,621 | -17.0% |
| Current portion of amounts payable after more than one year | 42 | €11,139 | €11,582 | +€443 | +4.0% |
| Trade debts | 44 | €84 | €37 | -€47 | -55.8% |
| Suppliers | 440/4 | €84 | €37 | -€47 | -55.8% |
| Taxes, remuneration and social security | 45 | €27,715 | €20,697 | -€7,017 | -25.3% |
| Taxes | 450/3 | €27,715 | €20,697 | -€7,017 | -25.3% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Accrued charges and deferred income | 492/3 | €0 | €720 | +€720 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,852 | €12,083 | +€231 | +1.9% |
| Other operating charges | 640/8 | €3,505 | €3,539 | +€35 | +1.0% |
| Gross operating margin | 9900 | €136,655 | €104,768 | -€31,887 | -23.3% |
| Operating profit (loss) | 9901 | €121,298 | €89,146 | -€32,152 | -26.5% |
| Financial income | 75/76B | €45 | €5,294 | +€5,249 | +11,647% |
| Recurring financial income | 75 | €45 | €5,294 | +€5,249 | +11,647% |
| Financial charges | 65/66B | €2,174 | €1,896 | -€277 | -12.7% |
| Recurring financial charges | 65 | €2,174 | €1,896 | -€277 | -12.7% |
| Profit (loss) for the period before taxes | 9903 | €119,170 | €92,544 | -€26,626 | -22.3% |
| Income taxes | 67/77 | €27,715 | €22,281 | -€5,434 | -19.6% |
| Profit (loss) for the period | 9904 | €91,455 | €70,263 | -€21,192 | -23.2% |
| Profit (loss) for the period to be appropriated | 9905 | €91,455 | €70,263 | -€21,192 | -23.2% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.